Akiko Ono
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akiko Ono has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Ansuya Naidoo
Medical Affairs, Norgine Limited, Uxbridge, United Kingdom
1 shared publication- Anurag K. Agrawal
American Cancer Society Atlanta Georgia USA
1 shared publication - Cristiano Spada
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
1 shared publication - Ervin Toth
Department of Gastroenterology, Skåne University Hospital, Lund University, Malmö, Sweden
1 shared publication - Ingrid Demedts
Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium
1 shared publication Jürgen F. Riemann
Klinikum Ludwigshafen, Ludwigshafen, Germany
1 shared publication
Latest Publications
- 1 May 2017
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 85 (5) , AB541
Tu1017 Pilot Results of the ECQI Self-Assessment Questionnaire to Evaluate Quality in Colonoscopy in Europe
- 1 May 2017
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 85 (5) , AB541
Tu1017 Pilot Results of the ECQI Self-Assessment Questionnaire to Evaluate Quality in Colonoscopy in Europe
- Open Access
- 7 August 2015
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 45 (10) , 900-905
Impact of screening colonoscopy on outcomes in colorectal cancer
Colorectal cancer is one of the most common cancers in both men and women worldwide and a good candidate for screening programs. There are two modalities of colorectal cancer screening: (i) population-based screening and (ii) opportunistic screening. The first one is based on organized, well-coordinated, monitored and established programs with a systematic invitation covering the entire target population. In contrast, opportunistic screening tests are offered to people who are being examined for other reasons. Recently, a variety of colorectal cancer screening tests have become available; each country should make a choice, based on national demographics and resources, on the screening method to be used. Fecal occult blood test, especially the fecal immunochemical test, would be the best modality for decreasing colorectal cancer mortality through population-based screening. In contrast, if the aim includes the early detection of colorectal cancer and adenomas, endoscopic methods are more appropriate.
- 7 August 2015
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 45 (10) , 900-905
Open AccessImpact of screening colonoscopy on outcomes in colorectal cancer
Colorectal cancer is one of the most common cancers in both men and women worldwide and a good candidate for screening programs. There are two modalities of colorectal cancer screening: (i) population-based screening and (ii) opportunistic screening. The first one is based on organized, well-coordinated, monitored and established programs with a systematic invitation covering the entire target population. In contrast, opportunistic screening tests are offered to people who are being examined for other reasons. Recently, a variety of colorectal cancer screening tests have become available; each country should make a choice, based on national demographics and resources, on the screening method to be used. Fecal occult blood test, especially the fecal immunochemical test, would be the best modality for decreasing colorectal cancer mortality through population-based screening. In contrast, if the aim includes the early detection of colorectal cancer and adenomas, endoscopic methods are more appropriate.